We recognise the value of health economics and real-world evidence in achieving market access. Obtaining reimbursement requires demonstrating the product’s clinical and economic benefits.
Our HEOR analysts have a track record of performing systematic and focused literature reviews.
They are proficient in tools such as RevMan, WinBugs, and STATA.
In health-care decisions, real-world data (RWD) and real-world evidence (RWE) are becoming increasingly important.
We may collect RWE for life science industry clients by reviewing claims and medical records and communicating the results to enable value demonstration.